Sign in

You're signed outSign in or to get full access.

Kimberly Box

Director at Cibus
Board

About Kimberly Box

Kimberly A. Box (65) was appointed to the Cibus, Inc. Board of Directors on September 11, 2025. She previously served as President & CEO of Gatekeeper Innovation, Inc. (acquired by RxGuardian) and spent 29 years at Hewlett Packard, most recently as Vice President, Global IT Services until 2009. She holds a B.S. in Business Administration (California State University, Chico), completed Wharton’s Executive Development Program, has NACD Directorship Certification™ (2021), and CERT in Cybersecurity Oversight (Carnegie Mellon, 2022) .

Past Roles

OrganizationRoleTenureCommittees/Impact
Gatekeeper Innovation, Inc. (acquired by RxGuardian)President & Chief Executive OfficerJoined 2016Company creates products to keep medications safe
Hewlett Packard (NYSE: HPQ)Vice President, Global IT Services; prior executive roles29-year career, left HP in 2009Led global IT services; broad technology operations background

External Roles

OrganizationRoleTenureCommittees/Impact
McGrath RentCorp (NASDAQ: MGRC)DirectorCurrentChair, Compensation Committee; member, Audit and Corporate Governance & Nominating Committees
Applied Science, Inc. (private)DirectorCurrentBoard service (private company)
American River Bank (NASDAQ: AMRB)DirectorFormer (until 2021 acquisition)Director until acquisition in 2021

Board Governance

  • Committee assignments: Compensation Committee; Nominating & Corporate Governance Committee; special committee evaluating strategic alternatives (all effective September 11, 2025) .
  • Independence: Nasdaq rules generally require committee members on Audit, Compensation, and Nominating to be independent; Cibus states these committees are composed of independent directors under applicable provisions . Appointment to these committees indicates the Board’s intent for independence.
  • Attendance and engagement: The Board held 24 meetings in 2024; each director on the Board attended more than 75% of Board and committee meetings; independent directors meet in executive session at least quarterly. Ms. Box joined in 2025; her attendance has not yet been reported .
  • Indemnification: Entered into Cibus’ standard director indemnification agreement at appointment .

Fixed Compensation

ComponentAmountTerms
Annual cash retainer$60,000Payable semi-annually; prorated for 2025 service from September 11, 2025
Equity compensation$90,000 grant date valueSubject to Board approval under the 2017 Omnibus Incentive Plan; typical non-employee director awards: U.S.-domiciled directors receive stock options with 10-year term, vesting by the earlier of first anniversary or next annual meeting; prorated for off-cycle appointments
Committee chair fees (policy)$10,000–$25,000Lead Director $25k; Comp Chair $12k; Nominating Chair $10k; Audit Chair $15k; Strategy Chair $25k; Ms. Box is not disclosed as a chair at Cibus

Director compensation is cash plus time-based equity; no meeting fees disclosed; awards vest based on continued service .

Performance Compensation

Performance MetricLink to Director PayNotes
None disclosedNot applicableCibus’ non-employee director compensation does not include performance-based metrics (equity awards vest on time/service) .

Other Directorships & Interlocks

CompanyIndustry Relationship to CBUSInterlock/Conflict Assessment
McGrath RentCorp (MGRC)Industrial equipment rentalNo CBUS-related party transactions disclosed for Ms. Box; standard independence affirmed at appointment
Applied Science, Inc.Private companyNo CBUS Item 404(a) related transactions disclosed
American River Bank (AMRB)Banking (former)Prior board role; no CBUS related-party exposure

Expertise & Qualifications

  • Technology operations and large-scale IT leadership (HP) .
  • CEO experience (Gatekeeper Innovation/RxGuardian) .
  • Public company governance depth; compensation, audit, nominating committee experience (MGRC) .
  • NACD Directorship Certification™ (2021) and CERT in Cybersecurity Oversight (2022) .
  • Recognized in NACD Directorship 100™; prior NACD Northern California Chapter Chair .

Equity Ownership

ItemDetail
Initial beneficial ownership (Form 3)Class A Common Stock: 0 shares; Direct ownership (D)
Filing detailsEvent date: 09/11/2025; Form 3 filed 09/26/2025; Attorney-in-Fact signature noted
Hedging/PledgingCompany policy prohibits hedging and generally restricts pledging/margin accounts; to the Company’s knowledge, no securities were pledged by any director in 2024

Insider Trades

FormDate of EventFiled DateSecurityAmountNotes
Form 309/11/202509/26/2025Class A Common Stock0Initial statement of beneficial ownership; direct (D)

Governance Assessment

  • Positive signals:

    • Appointment to Compensation and Nominating & Governance Committees places Ms. Box at the center of pay structure and governance oversight; Cibus uses an independent consultant (Aon) for compensation and reported no conflicts, supporting governance rigor .
    • Strong background in technology operations, cybersecurity oversight credentials, and public board committee leadership enhance board effectiveness for CBUS’ scaling/commercialization agenda .
    • No related-party transactions or Item 404(a) interests disclosed for Ms. Box at appointment .
  • Watchpoints:

    • Initial beneficial ownership was zero at appointment; alignment will depend on receipt/vesting of director equity awards over time. Equity ownership and any future changes should be monitored for “skin-in-the-game” alignment .
    • CBUS’ 2025 governance context includes proposals to reprice warrants for the Chairman and approvals for additional share issuances; continued robust independent committee scrutiny (including Ms. Box’s committees) is important to sustain investor confidence .
    • Multiple external board commitments (MGRC, ASI) require time management; no conflicts disclosed, but ongoing monitoring for potential interlocks with CBUS stakeholders is prudent .
  • Overall: Ms. Box’s committee placements, independence expectations, and governance credentials are supportive of board effectiveness. No direct conflicts are disclosed; adherence to hedging/pledging prohibitions further aligns with shareholder-friendly practices .